Immune response to COVID-19 Vaccination in people with Diabetes Mellitus - COVAC-DM study - Trial 2021-001459-15
Access comprehensive clinical trial information for 2021-001459-15 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Ongoing. The study focuses on Type 1 Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Medical University of Graz
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Difference in the change of anti-SARS-CoV-2 spike protein immune response measured by antigen-binding Ig assay from baseline to Visit 3 (2-3 weeks after the second vaccination) between people with diabetes (all 4 groups pooled) and healthy controls.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2021-001459-15
Non-Device Trial